Clinical trial
Scopolamine Treatment for Patients With Organophosphate Poisoning
NCT00389259 · Assaf-Harofeh Medical Center, Other · Withdrawn
Key facts
| NCT number | NCT00389259 |
|---|---|
| Title | Scopolamine Treatment for Patients With Organophosphate Poisoning |
| Official title | Scopolamine Treatment for Patients With Organophosphate Poisoning - a Randomized, Double Blind, Placebo-Controlled Study. |
| Lead sponsor | Assaf-Harofeh Medical Center, Other |
| Collaborators | Israeli MOH International Diabetes Federation |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Neurotoxicity Syndromes |
| Intervention type | Drug |
| Interventions | Placebo |
| Enrollment | 50 |
| Start date | Oct 1, 2007 |
| Completion | Dec 1, 2009 |
| First posted | Oct 18, 2006 |
| Last update posted | Apr 5, 2011 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: